Pharmaceutical unit dose packaging has gained gigantic popularity as it offers the patients a precise dose of medication as required. It is used for solid as well as liquid drugs and has numerous forms of packaging including pouches, vials, prefilled syringes, and blister cards. It also allows building consistency in the patient’s treatment plan and guarantees the best patient care.
The increase in adoption of automation of packaging lines in the pharmaceutical industry is the foremost factor that is primarily fueling the global pharmaceutical unit dose packaging market. Further, increase in demand for efficient & safe packaging of drug products and growing awareness among the patients to minimize the administration errors are fostering the growth of the market.
Also, increase in demand for single-dose packaged drugs specifically in clinical trials has led to a surge in demand for blister packaging. In addition to this, there is growing need for convenience and rise in number of vaccination programs particularly due to Covid-19 pandemic. All such factors are equally contributing to the growth of the global market. For instance, in June 2020, SCHOTT delivered pharmaceutical vials to package 2 billion doses of COVID-19 vaccines with an initial investment of €350 million. Furthermore, technological advancements resulting in smart packaging options may open up numerous opportunities for the growth of the global market during the forecast period.
The global pharmaceutical unit dose packaging market is segregated based on product, material, end-user, and region. Based on the product, the global market is categorized as blisters packaging, ampoules, vials, and prefilled syringes cartridges. The material segment consists of plastic & polymers, aluminum, glass, and paper pharmaceutical & paperboard. The end-use segment is split into ophthalmic, injectable, biologics, wound care, respiratory therapy, and orals.
Regionally, North America is estimated to lead the global pharmaceutical unit dose packaging market during the forecast period owing to growing number of clinical trials, increase in demand for unit dose packaging from homecare facilities, and geriatric population to minimize the administration errors. In addition to this, automation of packaging on large scale is also boosting the growth of the market in this region. On the other hand, Asia Pacific is anticipated to be the fastest growing region and contribute a significant share in the market during the forecast period. This is attributed to the growing number of vaccination programs due to the outbreak of Covid-19 and existence of pharmaceutical companies in countries like China & India.
Stevanato Group S.p.a., SGD SA, Schott AG, West Pharmaceutical Services, Inc., Gerresheimer AG, Comar LLC, Berry Global, Inc., Amcor plc, UDG Healthcare plc, and Klockner Pentaplast Group are some of the major players operating in the global pharmaceutical unit dose packaging market.